Physician Investigator (Cl) General Internal Medicine, Mass General Research Institute

Assistant Professor of Medicine Harvard Medical School

Assistant Physician Medicine-General Internal Medicine, Massachusetts General Hospital

MD 2004

emerging infectious disease; emigrants and immigrants; health disparities; hispanic populations; hiv infections; mycobacterium tuberculosis; office visits; patient acceptance of health care; transients and migrants; tuberculosis; urban health services

Julie Levison, MD, MPhil, MPH, FACP, is an Assistant Professor of Medicine at Harvard Medical School, and is board certified in infectious diseases. Her clinical interests are in general infectious diseases, HIV medicine, and immigrant health with a focus on a team-based, patient-centered approach to delivering infectious diseases specialty care in the community setting to diverse patient populations.

Her research focuses on understanding and addressing disparities in HIV outcomes in minority populations with specific attention to immigrant populations. She is principle investigator of an R01 award from the National Institute of Mental Health to evaluate a community health worker intervention to improve engagement in HIV care in Latino immigrants in Miami and Houston. She has developed novel tools to leverage the electronic medical record for HIV outcomes research with immigrant populations. Working in partnership with community agencies, government, and health care systems, Dr. Levison focuses on developing effective interventions to improve public health.

She is an active member of the Infectious Disease Society of America and the American College of Physicians, where she is a Fellow. She is also a Research Scientist in the National Hispanic Science Network. Dr. Levison was named to El Planeta’s Powermeter 100, a list of Massachusetts’ 2017 Most Influential People for Latinos. Dr. Levison is the recipient of the Arnold Gold Foundation Leonard Tow Humanism in Medicine Award from Harvard Medical School. She participates in pandemic preparedness at the local, state and national level and is a member of the Latinx Expert Panel for the National Institute of Allergy and Infectious Diseases COVID-19 Vaccine Prevention Network.

She is fluent in English and Spanish.